Pharma Deko Plc

NGX-PHARMDEKO
Nigerian Stock Exchange
Pharmaceutical Preparations
Global Rank
#49466
Country Rank
#141
Market Cap
259,331.6
Price
0.0012
Change (%)
0.00%
Volume
0

Pharma Deko Plc's latest marketcap:

259,331.6

As of 08/14/2025, Pharma Deko Plc's market capitalization has reached $259,331.6. According to our data, Pharma Deko Plc is the 49466th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 259,331.6
Revenue (ttm) 306,755.94
Net Income (ttm) -92,506.53
Shares Out 216.93 M
EPS (ttm) 0
Forward PE 0.00
Ex-Dividend Date 05/07/2018
Earnings Date 08/15/2025
Market Cap Chart
Data Updated: 08/14/2025

Pharma Deko Plc's yearly market capitalization.

Pharma Deko Plc has seen its market value grow from ₦214 M to ₦396.98 M since 2014, representing a total increase of 85.51% and an annual compound growth rate (CAGR) of 5.99%.
Date Market Cap(₦) Market Cap(USD) Change (%) Global Rank
08/14/2025 ₦396.98 M $259,331.6 0% 49466
12/31/2024 ₦396.98 M $238,190.89 0% 45181
12/29/2023 ₦396.98 M $428,743.61 -12.86% 43348
12/30/2022 ₦455.56 M $993,112.85 -4.55% 41085
12/30/2021 ₦477.25 M $1.13 M 46.67% 39325
12/31/2020 ₦325.4 M $836,265.15 0% 36202
12/31/2019 ₦325.4 M $881,820.45 -0% 33406
12/31/2018 ₦325.4 M $875,318.99 -36.44% 32271
12/29/2017 ₦511.95 M $1.4 M 32.58% 30749
12/30/2016 ₦386.16 M $1.25 M -20.84% 28734

Company Profile

About Pharma Deko Plc

Pharma Deko Plc is a Nigerian company specializing in the manufacturing, packaging, and marketing of pharmaceutical and consumer products. Established in 1962 and headquartered in Agbara, Nigeria, the company operates across three key segments:

Business Segments

  • Pharma: Produces a wide range of pharmaceutical products including syrups, drops, oral care medications, and more.
  • Consumer: Offers non-sugar carbonated soft drinks such as Sans Cream Soda and Bien flavored beverages.
  • Contract: Provides contract manufacturing and packaging services for pharmaceutical and fast-moving consumer goods.

Key Products

  • Pharmaceuticals: Vitacee, Pharmadec, Brett Mouthwash, Hexedene, Parkalin, Revitone Blood Tonic, Antasil, Omepraz, and Parkaprim.
  • Consumer Goods: Sans Cream Soda, Bien flavored drinks, and other non-sugar carbonated beverages.

Company History

Originally founded as Parke-Davis & Co. (Nig.) Limited in 1962, the company rebranded to Pharma Deko Plc in 1980. Today, it remains a key player in Nigeria's pharmaceutical and consumer goods industries.

Frequently Asked Questions

  • What is Pharma Deko Plc's (NGX-PHARMDEKO) current market cap?
    As of 08/14/2025, Pharma Deko Plc (including the parent company, if applicable) has an estimated market capitalization of $259,331.6 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Pharma Deko Plc global market capitalization ranking is approximately 49466 as of 08/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.